FDA withdraws two final guidances, pulls compliance deadlines for bone allograft makers
The FDA on Friday said it’s pulling two final guidance documents published earlier this year that sought to help entities manufacturing cell- and tissue-based medical …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.